Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer (NCT02107105)

🧪 Interventions in This Study

• Quality-of-Life Assessment (OTHER)
• Questionnaire Administration (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• M D Anderson Cancer Center — Houston, Texas

📞 Contact the Study Coordinator

Phone: (713) 792-6940

Email: GChang@mdanderson.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Rectal Adenocarcinoma

• Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma — Tampa, Florida
• ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer — Portland, Oregon
• ctDNA-Informed Management of Early-Stage Rectal Cancer — Sacramento, California
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors — Hartford, Connecticut
• Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer — Houston, Texas
• Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer — Portland, Oregon

Explore by condition: All Rectal Adenocarcinoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.